Robert Flavell, MD, PhD, is an Associate Professor and Division Chief of the Section of Molecular Imaging in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco.  Dr. Flavell’s laboratory focuses on the development of new molecular imaging and therapeutic tools for better understanding of disease progression in patients with prostate and other cancers. An area of major focus is the development of novel theranostic agents, where new therapies are paired with imaging agents against the same target. Dr. Flavell's research spans from basic chemistry and chemical biology projects, to translational and clinical studies.